Medicine and Dentistry
Insulin Dependent Diabetes Mellitus
60%
Diabetes
53%
Maturity Onset Diabetes of the Young
46%
Association
40%
Cardiovascular Disease
34%
Analysis
33%
COVID-19
31%
Age
29%
Genome Wide Association Study
29%
Screening
28%
Patient
25%
Biological Marker
24%
Cohort Analysis
24%
Rheumatoid Arthritis
23%
Diabetic Retinopathy
20%
Man
20%
Learning
18%
Gene Linkage
18%
Serum
17%
Woman
16%
Incidence
14%
Diabetic Nephropathy
13%
Prospective Cohort Study
13%
Therapeutic Procedure
12%
Chromosome
12%
Hospital
12%
Death
11%
Inpatient
11%
Retinopathy
11%
Nephropathy
11%
Drug
10%
Chemotherapeutic Agent
10%
Single Nucleotide Polymorphism
10%
Diagnosis
9%
Person
9%
Predictor
9%
Diabetic Ketoacidosis
9%
Ethnic Difference
9%
Deterioration
9%
Comorbidity
9%
Follow up
9%
Prevalence
9%
Mendelian Randomization Analysis
8%
Cancer Risk
8%
Male Type Alopecia
8%
Observational Study
8%
Disease Exacerbation
8%
Health Outcomes
8%
Phenome
8%
Linkage Analysis
8%
Biochemistry, Genetics and Molecular Biology
Association
100%
Nested Gene
54%
Genetics
45%
Genome-Wide Association Study
44%
Sample
33%
Mendelian Randomization
25%
Single Nucleotide Polymorphism
22%
Statin
19%
Single-Nucleotide Polymorphism
19%
Genotype
17%
Age
17%
Pleiotropy
16%
Uric Acid Blood Level
14%
Genetic Divergence
13%
Expression Quantitative Trait Loci
13%
Quantitative Trait Locus
13%
Gene Expression
13%
Learning
12%
Prevalence
12%
Chromosome
12%
Time
12%
Genotyping
12%
Tumor Necrosis Factors
10%
Kidney Function
10%
Phenotype
9%
Sample Size
9%
Case-Control Study
9%
Gene Locus
9%
Cholesterol
9%
Secretion (Process)
8%
Vitamin D
8%
Immunoglobulin G
8%
Identity
8%
SLC2A9
8%
Glycome
8%
C-Peptide
8%
Electric Potential
8%
Genetic Architecture
8%
Allele
8%
Glycosylation
7%
Heritability
7%
Genetic Linkage
6%
Polysaccharides
6%
Pedigree
6%
Metabolite
6%
Mouse
6%
Health
6%
Molecule
6%
Albumin
6%
Creatinine
6%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
24%
Drug
22%
Insulin Dependent Diabetes Mellitus
22%
Diabetes Mellitus
20%
Biological Marker
13%
Diseases
10%
Kidney Disease
9%
Disease Exacerbation
8%
Pioglitazone
8%
Polypharmacy
8%
Coronavirinae
8%
Incidence
7%
Deterioration
7%
Hemoglobin A1c
7%
Prevalence
6%
Chronic Kidney Failure
5%
Beta 2 Microglobulin
5%
Case-Control Study
5%
Statin (Protein)
5%
Cohort Study
5%
Cardiovascular Risk
5%
Metformin
5%
Rosiglitazone
5%
Comorbidity
5%
Death
5%
Complication
5%
Glucose
5%
